Skip to content

About us

eCounsel group

A boutique firm with unparalleled expertise in business and technology. We have good command of industrial ecology and legal practice, and have undertaken highly regarded cases. Because the small business scope, we pay more emphasis on effectiveness and efficiency, and choose clients with deliberation. The managing partner not only has extensive experiences in various legal issues more over than 20 years, but invests and manages several technology companies. In addition, he always checks each case rigorously. Clients’ business objectives are our primary focus. To achieve the same in the most cost-effective fashion trumps all seemingly sophisticated legal discussions.

Caught in the Middle : Korea's next Move Against U.S and China

2014 - 11 - 27

Love it or hate it, just like U.S military’s global power projection, the rise of China is as much an issue that we can’t avoid. From our perspective, we hate Washington more than Beijing. But we have spent as much time visiting and learning form both countries for the past 20 years.

不論愛恨情仇,中國崛起是無法迴避的議題,就如同美國在全球的軍事影響力一樣。在我們看來,比起北京,更討厭華盛頓;但是,我們近二十年來,花在造訪這兩個國家並且努力吸收其思惟的時間,幾乎一樣多。

‪我們的中心思想‬

夾在兩強之間、左右為難,這點沒什麼,大家都是半斤八兩。讀者若認為美國狀似鴨霸,其立場就很容易拿捏吧? 重點在於自己有沒有中心思想。我們的中心思想始終還算明確:「窮盡在任何國家能借助取用的資源,讓我們立足於台灣的各個創業最佳化,免於單一影響力之宰制」。

從1996年起,我們就頻繁前往北京與上海出差,雖然覺得必須從香港澳門濟州島轉機得耗掉大半天實在煩人,但畢竟也眼界大開。其中,兩個現象讓我們十分驚訝。一,為了學習中文瞭解中國,南韓企業大量派駐數以千計的員工過去;二,在北京的諸多高爾夫球場上幾乎有半數是南韓人。這兩個狀似與直接產值無關的小事,比起過去那兒投資設廠的意涵還深。

果不其然,現在對中國出口已占南韓整體五千六百億美金出口貿易額的25%了。

“As South Korean manufacturers relocate to reduce costs and entrench themselves in China’s huge market, trade has shot up. Last year, China accounted for a quarter of South Korea’s $560 billion in total exports. The U.S. share stood at 11%, down from around 40% in the 1980s.”[1]

再看看華爾街日報中的這張圖。
South Korea Looks to Prosper in China While Staying Close to U.S.

「南韓如今已躍居對中國的投資大戶,投資金額幾乎超越經濟規模比自己大上許多的日本。中國官方數據顯示,南韓企業今年1至9月在中國投資32億美元設廠,較去年同期成長三分之一」[2]

“Cultural ties also have grown. Today, there are almost as many South Korean students enrolled at colleges in China as in the U.S. Last year, Chinese tourists were the largest group of visitors to South Korea.”[1]

南韓的大學生留學中國的人數已幾乎等同留美人數,而在觀光客裡,來自中國的人數也是最多的。

那麼,首爾的中心思想究竟是什麼呢? 我們開始好奇了。老實講,除了茶餘飯後的笑談話題之外,以前從來沒把南北韓當回事過。至盼能藉著南韓行和Kindle上買來的兩本書,略略以管窺天。

資料來源:
[1] South Korea Looks to Prosper in China While Staying Close to U.S.(Wall Street Journal)
[2] 南韓加碼大陸 快超越日本-經濟日報

Recommended article 

Minimum Beautiful Product

Style never met and those among great. At no or september sportsmen he perfectly happiness attending. Depending listening delivered off new she procuring satisfied sex existence. Person plenty answer to exeter it if. Law use assistance…

The Core Problem of Taiwan's National Health Insurance

Our health insurance is a public insurance. It should not operate like a private one. The reimbursements should only cover generic drugs not brand-name drugs. 新聞眼/加錢可選原廠藥 醫療階級化 「……國人就醫用藥將有重大變革。衛福部指示健保署試辦「藥品差額負擔試辦計畫」,明年一月一日起,比照人工水晶體、心血管支架等醫材,針對部分健保未給付的原廠藥,以學名藥價給付,民眾若負擔價差,就能使用原廠藥…」 「……民眾對於藥品常處於資訊弱勢,差額負擔會讓民眾誤以為藥品療效有差異;若是必要使用的藥品,就應健保給付,何必要民眾自行負擔?若訂定差額負擔,民眾就醫會被依財力來分等級,甚至可能引發醫院誘導患者選擇自費藥品,恐造成有錢買生,沒錢買死…」 http://ppt.cc/z90o8 綜觀本篇新聞報導內容,撰稿者顯未探究健保作為「社會保險」的本質為何。 對於政府的作為,我很少表達肯定。對於我自己、對我自己所創立的各個事業,更是這樣。不自我鞭策,哪來的進步? 但衛福部的這一步,我則認為,是終於找到正確的方向了。 我在四年前受亞洲藥學會 (FAPA) 的邀請,在第一屆學名藥研討會中發表了…

Caught in the Middle : Korea's next Move Against U.S and China

Love it or hate it, just like U.S military’s global power projection, the rise of China is as much an issue that we can’t avoid. From our perspective, we hate Washington more than Beijing. But we…